Incyte Stock Technical Analysis
| INCY Stock | USD 100.07 1.01 1.00% |
As of the 2nd of February, Incyte retains the Downside Deviation of 1.99, market risk adjusted performance of 0.1735, and Risk Adjusted Performance of 0.0496. Incyte technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Incyte Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Incyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IncyteIncyte's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Incyte Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 102.33 | Buy | 27 | Odds |
Most Incyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Incyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Incyte, talking to its executives and customers, or listening to Incyte conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. Market participants price Incyte higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Incyte assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 2.907 | Earnings Share 5.85 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets |
Understanding Incyte requires distinguishing between market price and book value, where the latter reflects Incyte's accounting equity. The concept of intrinsic value—what Incyte's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Incyte's price substantially above or below its fundamental value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Incyte's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Incyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Incyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Incyte.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Incyte on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Incyte or generate 0.0% return on investment in Incyte over 90 days. Incyte is related to or competes with United Therapeutics, Genmab AS, Royalty Pharma, Quest Diagnostics, Zimmer Biomet, West Pharmaceutical, and Waters. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprie... More
Incyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Incyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Incyte upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.99 | |||
| Information Ratio | 0.0395 | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 4.1 |
Incyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Incyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Incyte's standard deviation. In reality, there are many statistical measures that can use Incyte historical prices to predict the future Incyte's volatility.| Risk Adjusted Performance | 0.0496 | |||
| Jensen Alpha | 0.0984 | |||
| Total Risk Alpha | 0.0148 | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | 0.1635 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Incyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Incyte February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0496 | |||
| Market Risk Adjusted Performance | 0.1735 | |||
| Mean Deviation | 1.59 | |||
| Semi Deviation | 1.76 | |||
| Downside Deviation | 1.99 | |||
| Coefficient Of Variation | 1690.75 | |||
| Standard Deviation | 2.29 | |||
| Variance | 5.22 | |||
| Information Ratio | 0.0395 | |||
| Jensen Alpha | 0.0984 | |||
| Total Risk Alpha | 0.0148 | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | 0.1635 | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 4.1 | |||
| Downside Variance | 3.96 | |||
| Semi Variance | 3.09 | |||
| Expected Short fall | (1.77) | |||
| Skewness | 0.8269 | |||
| Kurtosis | 2.63 |
Incyte Backtested Returns
Incyte holds Efficiency (Sharpe) Ratio of -0.0124, which attests that the entity had a -0.0124 % return per unit of risk over the last 3 months. Incyte exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Incyte's Risk Adjusted Performance of 0.0496, downside deviation of 1.99, and Market Risk Adjusted Performance of 0.1735 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.77, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Incyte's returns are expected to increase less than the market. However, during the bear market, the loss of holding Incyte is expected to be smaller as well. At this point, Incyte has a negative expected return of -0.0251%. Please make sure to check out Incyte's potential upside, and the relationship between the jensen alpha and accumulation distribution , to decide if Incyte performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.03 |
Very weak reverse predictability
Incyte has very weak reverse predictability. Overlapping area represents the amount of predictability between Incyte time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Incyte price movement. The serial correlation of -0.03 indicates that only 3.0% of current Incyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 8.23 |
Incyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Incyte Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Incyte volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Incyte Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Incyte on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Incyte based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Incyte price pattern first instead of the macroeconomic environment surrounding Incyte. By analyzing Incyte's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Incyte's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Incyte specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Payables Turnover | 2.88 | 1.91 | 1.72 | Days Of Inventory On Hand | 72.93 | 56.89 | 51.2 |
Incyte February 2, 2026 Technical Indicators
Most technical analysis of Incyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Incyte from various momentum indicators to cycle indicators. When you analyze Incyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0496 | |||
| Market Risk Adjusted Performance | 0.1735 | |||
| Mean Deviation | 1.59 | |||
| Semi Deviation | 1.76 | |||
| Downside Deviation | 1.99 | |||
| Coefficient Of Variation | 1690.75 | |||
| Standard Deviation | 2.29 | |||
| Variance | 5.22 | |||
| Information Ratio | 0.0395 | |||
| Jensen Alpha | 0.0984 | |||
| Total Risk Alpha | 0.0148 | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | 0.1635 | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 4.1 | |||
| Downside Variance | 3.96 | |||
| Semi Variance | 3.09 | |||
| Expected Short fall | (1.77) | |||
| Skewness | 0.8269 | |||
| Kurtosis | 2.63 |
Incyte February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Incyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.02 | ||
| Daily Balance Of Power | (0.51) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 100.27 | ||
| Day Typical Price | 100.20 | ||
| Price Action Indicator | (0.70) | ||
| Market Facilitation Index | 1.97 |
Additional Tools for Incyte Stock Analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.